Acute Effects of Whole-body Vibration Training in Hypoxia and Normoxia in Multiple Sclerosis Patients
1 other identifier
interventional
13
1 country
1
Brief Summary
Multiple Sclerosis (ME) is a degenerative, inflammatory and autoimmune demyelinating disease of the central nervous system, characterized by demyelination due to inflammation and degeneration of the myelin sheaths enveloping nerves of the eye, periventricular grey matter, brain, spinal cord and brainstem. The symptoms associated with MS include symptomatic fatigue, muscle weakness, ataxia, mobility and balance problems or cognitive problems. Moderate intensity strength training has been shown to improve strength and mobility in persons with MS. It was suggested that whole-body vibration training (WBVT) is effective to improve muscle strength, such as resistance training, resulting from both neural and structural adaptations. On the other hand, traditional strength training in hypoxia has garnered much attention. This method has shown improvements in isometric strength and increases in muscle size.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable multiple-sclerosis
Started Jun 2018
Shorter than P25 for not_applicable multiple-sclerosis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 15, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2018
CompletedFirst Submitted
Initial submission to the registry
February 13, 2019
CompletedFirst Posted
Study publicly available on registry
February 27, 2019
CompletedFebruary 27, 2019
February 1, 2019
2 months
February 13, 2019
February 25, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (12)
Maximal Voluntary Isometric Contraction of Knee Extension
Immediately before the training sessions
Maximal Voluntary Isometric Contraction of Knee Extension
Immediately after the training sessions
Rate of Force Development
Immediately before the training sessions
Rate of Force Development
Immediately after the training sessions
Central Activation Ratio
Immediately before the training sessions
Central Activation Ratio
Immediately after the training sessions
Biomechanical study of the walk by video recording
Kinematic analysis of knee and ankle angles during walking
Immediately before the training sessions
Biomechanical study of the walk by video recording
Kinematic analysis of knee and ankle angles during walking
Immediately after the training sessions
Biomechanical study of the walk by video recording
Stride amplitude during walking
Immediately before the training sessions
Biomechanical study of the walk by video recording
Stride amplitude during walking
Immediately after the training sessions
Spasticity
Pendulum test
Immediately before the training sessions
Spasticity
Pendulum test
Immediately after the training sessions
Secondary Outcomes (8)
Rate of Perceived Exertion
Immediately before the training sessions
Rate of Perceived Exertion
Immediately after the training sessions
Walking speed
Immediately before the training sessions
Walking speed
Immediately after the training sessions
Static balance
Immediately before the training sessions
- +3 more secondary outcomes
Study Arms (2)
Whole-body vibration in normoxia condition
EXPERIMENTALTraining session in normoxia condition
Whole-body vibration in hypoxia condition
EXPERIMENTALTraining session in hypoxia condition
Interventions
Whole-body vibration training in hypoxia and normoxia condition
Eligibility Criteria
You may qualify if:
- mild or moderate disability with clinical mild spastic-ataxic gait disorder.
- stable phase of the disease.
You may not qualify if:
- Expanded Disability Status Scale (EDSS) \< 6.
- relapsing disease within the preceding 12 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidad Católica San Antonio
Murcia, 30107, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Profesor Titular
Study Record Dates
First Submitted
February 13, 2019
First Posted
February 27, 2019
Study Start
June 15, 2018
Primary Completion
July 30, 2018
Study Completion
August 30, 2018
Last Updated
February 27, 2019
Record last verified: 2019-02